Latest filing published 15 May 2024 for LIPELLA PHARMACEUTICALS INC., €7,018.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -64.3%Entry US$6.10 · Close at T+365 US$2.18
- -59.4%Entry US$6.40 · Close at T+365 US$2.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jonathan H. Kaufman: trading record in brief
Jonathan H. Kaufman discloses dealings in Lipella Pharmaceuticals Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 13 March 2024 and the latest from 14 May 2024.
On the market, this insider has only ever bought: 3 purchases, €49k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant.
The median purchase comes to €20k.
Most recently, on 15 May 2024, the filings show an open-market purchase worth €7,018 in Lipella Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan H. Kaufman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.7595.8% of flowCommon StockSEC:0001753926-24-000984:0Canonical exit: 12 Aug 2024 (T+90)
- 25,000 shares@ US$0.8721Common StockSEC:0001753926-24-000573:1Canonical exit: 17 Jun 2024 (T+90)
- 30,000 shares@ US$0.788318.1% of flowCommon StockSEC:0001753926-24-000573:0Canonical exit: 16 Jun 2024 (T+90)
- 144,906 shares@ US$0.690176.1% of flowCommon StockSEC:0001753926-24-000541:0
4 of 4 declarations